An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast Cancer
NCT ID: NCT02286362
Last Updated: 2017-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
510 participants
OBSERVATIONAL
2015-01-14
2016-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with HER2-positive early breast cancer who according to national guidelines are eligible for neoadjuvant or adjuvant HER2+ treatment
* Patients for whom the investigator has decided to start a treatment with Herceptin SC
* Trastuzumab treatment naive or non-naive (previously intravenous treatment)
* Informed consent
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Du Docteur Calabet; Cromg
Agen, , France
C H Du Pays D'Aix En Provence; Hopital De Jour
Aix-en-Provence, , France
Ch Du Pays D Aix; Maternite Gynecologie
Aix-en-Provence, , France
Poly Parc Rambot La Provencale; Chimiotherapie Ambulatoire
Aix-en-Provence, , France
Centre Hospitalier Albi; Oncologie
Albi, , France
Clinique Claude Bernard; Onco Hematologie
Albi, , France
Hopital Prive D Antony; Oncologie
Antony, , France
Cmc De Tronquieres;Chimiotherapie Et Radiotherapie
Aurillac, , France
Ch D Auxerre; Oncologie
Auxerre, , France
Clinique Du Docteur Maymard; Hopital De Jour Chimiotherapie
Bastia, , France
Hopital De Falconaja Furiani; Hopital De Jour
Bastia, , France
Centre Oncologie Du Pays Basque
Bayonne, , France
HOPITAL JEAN MINJOZ; Oncologie
Besançon, , France
Centre Pierre Curie
Beuvry, , France
Ch De Beziers; Hematologie
Béziers, , France
Hopital Avicenne; Cancerologie
Bobigny, , France
Clinique Tivoli; Chimiotherapie Radiotherapie
Bordeaux, , France
Polyclinique Bordeaux Nord Aquitaine; Chimiotherapie Radiotherapie
Bordeaux, , France
Centre Hospitalier Fleyriat; Oncologie/Hematologie
Bourg-en-Bresse, , France
Hopital Augustin Morvan; Federation De Cancerologie
Brest, , France
Clinique Pasteur Lanroze; Chimiotherapie Radiotherapie
Brest, , France
CMC de Bligny; Oncologie Court Sejour
Briis-sous-Forges, , France
Hopital Pierre Nouveau; Medecine A
Cannes, , France
CH Carcassonne; Service Onco Hematologie
Carcassonne, , France
Clinique Montreal; Chimiotherapie
Carcassonne, , France
Medipole De Savoie; Departement Oncologie
Challes-les-Eaux, , France
Hopital Prive Paul d Egine; Chimiotherapie Ambulatoire
Champigny-sur-Marne, , France
CH de Cholet; oncologie
Cholet, , France
Hopital Antoine Beclere; Hopital De Jour
Clamart, , France
Centre De Radiotherapie Et D'Oncologie; Oncologie
Compiègne, , France
Groupe Hospitalier Public Du Sud De L'Oise GHPSO; Oncologie
Creil, , France
Chi De Creteil; Radiotherapie Oncologie
Créteil, , France
Hopital Henri Mondor; Oncologie Medicale
Créteil, , France
Centre Leonard De Vinci;Chimiotherapie
Dechy, , France
Centre De Radiotherapie Du Parc
Dijon, , France
Ch De La Dracenie; Hopital De Jour
Draguignan, , France
Clinique Claude Bernard; Chimiotherapie
Ermont, , France
Chi Emile Durkheim Site Epinal; Oncologie
Épinal, , France
Chi De Frejus Saint Raphael; Oncologie
Fréjus, , France
Chi Alpes Du Sud Site De Gap; Med Interne Et Polyvalente
Gap, , France
Centre Mistral; Chirurgie Cancerologie Gynecologiques
Guilherand-Granges, , France
CH de Marne la vallee; Oncologie Medicale
Jossigny, , France
Hopital Albert Michallon; Oncologie
La Tronche, , France
Hopital Louis Pasteur; Oncologie Hematologie
Le Coudray, , France
Ch Du Mans; Medecine Hematologie Oncologie
Le Mans, , France
Polyclinique Du Bois; Oncologie
Lille, , France
Clinique Chenieux; Oncology
Limoges, , France
Ch De Longjumeau; Hopital De Jour Et Semaine
Longjumeau, , France
Ch De Lons Le Saunier; Medecine 5
Lons-le-Saunier, , France
Ch Bretagne Sud Site Scorff; Oncologie Medicale
Lorient, , France
Clinique De La Sauvegarde; Chimiotherapie
Lyon, , France
Clinique Saint Faron; Sce Oncologie Radiotherapie
Mareuil-lès-Meaux, , France
Ctre Hosp Prive Beauregard; Hop De Jour Chimiotherapie
Marseille, , France
Hopital Clinique Claude Bernard; Oncologie Medicale
Metz, , France
Hopital Layne; Medecine Ambulatoire
Mont-de-Marsan, , France
Ghi Le Raincy Montfermeil; Oncologie Medicale
Montfermeil, , France
Ch De Montlucon; Hematologie Cancerologie
Montluçon, , France
Clinique Clementville; Hopital De Jour
Montpellier, , France
Polyclinique Gentilly; CHIMIOTHERAPIE AMBULATOIRE
Nancy, , France
Centre Catherine de Sienne; Chimiotherapie
Nantes, , France
Polyclinique Du Languedoc; Chimiotherapie
Narbonne, , France
Ch Georges Renon; Oncologie Radiotherapie
Niort, , France
Hopital Caremeau; Hematologie Oncologie
Nîmes, , France
Hopital Caremeau; Maternite Gynecologie
Nîmes, , France
Clinique Valdegour
Nîmes, , France
CROM
Osny, , France
Ch Pitie Salpetriere; Oncologie Medicale
Paris, , France
GH Paris Saint Joseph; Hopital De Jour Oncologie
Paris, , France
Ch Francois Mitterrand; Medecine Oncologie
Pau, , France
Centre Catalan D' Oncologie
Perpignan, , France
Hopital Saint Jean; Centre Henri Pujol
Perpignan, , France
Polyclinique Francheville; Med Chimiotherapie Radiotherapie
Périgueux, , France
CH Rene Dubos; Oncologie
Pontoise, , France
CH Annecy Genevois site Annecy; Oncologie
Pringy, , France
Chi De Cornouaille; Oncologie Hospitalisation
Quimper, , France
Institut Jean Godinot; Pavillon Rubis
Reims, , France
Clinique de la Theuillerie; Oncologie
Ris-Orangis, , France
Clinique Armoricaine Radiologie; Cons Externes
Saint-Brieuc, , France
Clinique Francois 1er; Service De Chimiotherapie
Saint-Dizier, , France
Chp Saint Gregoire; Cancerologie Radiotherapie
Saint-Grégoire, , France
Clinique de L'Union; Oncologie
Saint-Jean, , France
CH de Saint Jean De Maurienne; Had St Jean De Maurienne
Saint-Jean-de-Maurienne, , France
Clinique Mutualiste L Estuaire
Saint-Nazaire, , France
Centre Hospitalier De Sens; Medecine Generale Oncologie
Sens, , France
Ch Gaston Ramon; Hopital De Jour
Sens, , France
Centre Clinical; Oncologie Medicale
Soyaux, , France
Clinique De L Estree; Oncologie Medicale
Stains, , France
Clinique Medico Chir Charcot; Chir Cancerologie
Ste Foy Les Lyon, , France
Institut D Oncologie Medical
Strasbourg, , France
Strasbourg Oncologie Libérale
Strasbourg, , France
Hopital Civil; Hematologie Oncologie
Strasbourg, , France
Hopitaux Du Leman Site Thonon; Maternite Gynecologie
Thonon-les-Bains, , France
Clinique Pasteur; Oncologie Medicale
Toulouse, , France
Clinique Saint Jean Languedoc; Oncologie Medicale
Toulouse, , France
Hopital Bretonneau; Clinique D'Oncologie & de Radiotherapie
Tours, , France
Centre Alexis Vautrin; Oncologie Medicale
Vandœuvre-lès-Nancy, , France
Hopital Prive Villeneuve d Ascq;Chimiotherapie Radiotherapie
Villeneuve-d'Ascq, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML28983
Identifier Type: -
Identifier Source: org_study_id